Skip to search formSkip to main contentSkip to account menu

cinaciguat

Known as: 4-(((4-Carboxybutyl)(2-(2-((4-(2-Phenylethyl)Phenyl)Methoxy)Phenyl)Ethyl)Amino)Methyl)Benzoic Acid 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

BAY 58-2667

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate… 
2019
2019
sGC Stimulators and Activators
Nitric oxide (NO)-soluble guanylate cyclase(sGC)-cGMP signalling is impaired in HF syndromes, which could predispose to vascular… 
2016
2016
[Expression of PAI-2 mRNA in peripheral blood leucocytes and regulation by sGC activator in pulmonary hypertension].
OBJECTIVE To investigate the mRNA expression level of plasminogen activator inhibitor-2 (PAI-2) in peripheral blood leucocytes… 
Review
2016
Review
2016
Treatment of hypoxemic respiratory failure in neonates: past, present and future
Despite advances in the field of neonatology, hypoxemic respiratory failure (HRF) and persistent pulmonary hypertension of the… 
2015
2015
NO/GMP as mediators of estrogen effects in bone
2011
2011
Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies
2010
2010
CINACIGUAT, A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, UNLOADS THE HEART IN ACUTE DECOMPENSATED HEART FAILURE
2010
2010
Cinaciguat (A Soluble Guanylate Cyclase Activator)
Highly Cited
2009
Highly Cited
2009
Cinaciguat ( BAY 58 – 2667 ) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure
Background—Cinaciguat (BAY 58–2667) is the first of a new class of soluble guanylate cyclase activators in clinical development… 
2009
2009
Pharmacological activation of soluble guanylate cyclase activator protects the heart against isoproterenol-induced myocardial ischemia in rats
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)